<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Teniloxazine</id>
	<title>Teniloxazine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Teniloxazine"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Teniloxazine&amp;action=history"/>
	<updated>2026-04-27T03:25:26Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Teniloxazine&amp;diff=5809511&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Teniloxazine&amp;diff=5809511&amp;oldid=prev"/>
		<updated>2024-05-22T17:54:03Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[File:Teniloxazine.svg|thumb|Teniloxazine.svg]] &amp;#039;&amp;#039;&amp;#039;Teniloxazine&amp;#039;&amp;#039;&amp;#039; is a [[pharmaceutical drug]] that belongs to the class of [[antidepressants]]. It is primarily used in the treatment of [[depression]] and has been studied for its potential effects on various [[neurotransmitter]] systems in the [[brain]].&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
Teniloxazine functions as a [[norepinephrine reuptake inhibitor]] (NRI), which means it increases the levels of [[norepinephrine]] in the [[synaptic cleft]] by inhibiting its reabsorption into the [[presynaptic neuron]]. This action is believed to contribute to its [[antidepressant]] effects. Additionally, Teniloxazine has been shown to have some activity on the [[dopamine]] and [[serotonin]] systems, although its primary mechanism of action is through norepinephrine reuptake inhibition.&lt;br /&gt;
&lt;br /&gt;
==Clinical Use==&lt;br /&gt;
Teniloxazine is prescribed for the treatment of [[major depressive disorder]] (MDD). It may be used as a monotherapy or in combination with other [[antidepressants]] depending on the patient&amp;#039;s response to treatment. The drug is typically administered orally in the form of tablets.&lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
Common side effects of Teniloxazine include [[nausea]], [[dry mouth]], [[insomnia]], and [[dizziness]]. More severe side effects can include [[hypertension]], [[tachycardia]], and [[anxiety]]. Patients are advised to report any unusual symptoms to their healthcare provider.&lt;br /&gt;
&lt;br /&gt;
==Contraindications==&lt;br /&gt;
Teniloxazine is contraindicated in patients with a known hypersensitivity to the drug or any of its components. It should be used with caution in patients with a history of [[cardiovascular disease]], [[hypertension]], or [[seizure disorders]].&lt;br /&gt;
&lt;br /&gt;
==Interactions==&lt;br /&gt;
Teniloxazine may interact with other medications, including other [[antidepressants]], [[antihypertensive drugs]], and [[monoamine oxidase inhibitors]] (MAOIs). It is important for patients to inform their healthcare provider of all medications they are currently taking to avoid potential drug interactions.&lt;br /&gt;
&lt;br /&gt;
==Research==&lt;br /&gt;
Ongoing research is exploring the broader applications of Teniloxazine in treating other conditions such as [[attention deficit hyperactivity disorder]] (ADHD) and [[chronic pain]]. Studies are also investigating its long-term efficacy and safety profile.&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[Antidepressant]]&lt;br /&gt;
* [[Norepinephrine reuptake inhibitor]]&lt;br /&gt;
* [[Major depressive disorder]]&lt;br /&gt;
* [[Neurotransmitter]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Antidepressants]]&lt;br /&gt;
[[Category:Norepinephrine reuptake inhibitors]]&lt;br /&gt;
[[Category:Pharmacology]]&lt;br /&gt;
[[Category:Psychiatry]]&lt;br /&gt;
&lt;br /&gt;
{{medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>